The Trump administration has ceased federal funding for sex reassignment surgeries and hormone therapies for minors. This decision impacts access to medical care for transgender and gender non-conforming youth. The funding cuts were reported by RT.com, detailing the administration's move to restrict resources for these specific treatments. Advocates express concern this will disproportionately affect vulnerable youth and limit their healthcare options. Further details regarding the scope of the funding termination and potential impacts are expected to emerge. The move aligns with previous actions taken by the administration concerning transgender rights and healthcare policies. This decision is likely to face legal challenges and spark further debate surrounding transgender rights in the US.